A new treatment for lung cancer is proving so successful it’s being hailed as a lung cancer vaccine…
A new anti-lung cancer drug developed in Cuba is being hailed as a ‘vaccine’ for the fatal disease that kills almost 1.5 million people every year.
Although the new drug is not a true vaccine – it does not actually prevent cancer – it has been shown to greatly reduce the symptoms enough to make the disease much more manageable.
New Treatment For Lung Cancer Shows Promise
The drug known as CimaVax-EGF, works by targeting the specific proteins responsible for the proliferation of cancer. By generating antibodies to combat these proteins, the CimaVax-EGF effectively limits the damage the cancer can cause.
Unfortunately the drug does not make the patient feel 100 percent better but it has been shown to keep them alive, even those diagnosed with stage 3 and 4 cancer who have not responded to other types of treatment.
CimaVax-EGF is the result of a 25 year project at Havana’s Center for Molecular Immunology, and has already been tested in over 1000 clinical trials, with much success. So much so that the drug is already being used in conjunction with chemo and radiotherapy, and is available free of charge to all hospitals on the island.
The drug is still undergoing trials, however if it proves successful, CimaVax-EGF could turn the fatal killer into a more manageable chronic disease.
No comments:
Post a Comment